Search results for Anti-Notch1 Antibody

Anti-Notch1 Antibody, Covalab, Ref 00123862

Anti-NOTCH1 Antibody (R1W80), AntibodySystem, RHE48306

Anti-Notch1 antibody [E6], Abcam, AB245686

Anti-Notch1 antibody [EP1238Y], Abcam, AB52627

Notch 1 (encoded by the Notch 1 gene) is a member of the Notch family of receptors. When bound to a ligand, the Notch1 receptor sends signals critical for normal development of many tissues throughout the body. Notch1 signalling supports the determination and specialization of cells as well as playing a role in cell proliferation, differentiation, and apoptosis. Product Specifications Anti-Notch1 antibody [EP1238Y] (ab52627) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P, WB in human, mouse samples. Anti-Notch1 antibody [EP1238Y] (ab52627) specifically detects Notch1 (UniProt ID: P46531; Molecular weight: 271kDa) and is sold in 100 µL and 1 mL selling sizes. Quality and Validation Abcam's high quality manufacturing and validation processes ensure Anti-Notch1 antibody [EP1238Y] (ab52627) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-Notch1 antibody [EP1238Y] (ab52627) has been confirmed by testing in knockout samples. Anti-Notch1 antibody [EP1238Y] (ab52627) has been cited over 201 times in peer reviewed journals and is trusted by the scientific community. Anti-Notch1 antibody [EP1238Y] (ab52627) has 17 independent reviews from customers. Related Products Antibody clone EP1238Y is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 647, PE, APC, HRP, Alkaline Phosphatase, Alexa Fluor® 488, Alexa Fluor® 594, Alexa Fluor® 555, Alexa Fluor® 750 ( ab194122 , ab303041 , ab303042 , ab303043 , ab308809 , ab309758 , ab310540 , ab315420 , ab321656 ). Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Notch1 Antibody (N253/10), AntibodySystem, RHE48304

Anti-Notch1 Antibody (N253/27), AntibodySystem, RHE48302

Anti-Notch1 Antibody (N253/32), AntibodySystem, RHE48303

PE Anti-Notch1 antibody [EP1238Y], Abcam, AB303041

This conjugated primary antibody is “made to order” and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link® conjugation technology, Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. This product is FOR RESEARCH USE ONLY. For commercial use, please contact [email protected]. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

APC Anti-Notch1 antibody [EP1238Y], Abcam, AB303042

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

FITC Anti-Notch1 antibody [mN1A], Abcam, AB80045